Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(892/week)
Manufacturing
(447/week)
Technology
(894/week)
Energy
(333/week)
Other Manufacturing
(284/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
PANTHERx Rare Pharmacy
Aug 13, 2025
PANTHERx® Rare Selected by Insmed to Dispense BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
Mar 24, 2025
PANTHERx® Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE(TM) (vigabatrin) Oral Solution
Dec 23, 2024
Neurocrine Biosciences, Inc. Selects PANTHERx®Rare Specialty Pharmacy for Distribution of Crenessity(TM) (crinecerfont)
Dec 23, 2024
PANTHERx® Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA(TM) (olezarsen)
Nov 26, 2024
BridgeBio Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Attruby(TM) (acoramidis)
Sep 03, 2024
PANTHERx® Rare Selected by Calliditas Therapeutics as Specialty Pharmacy for TARPEYO®
Jul 25, 2024
PANTHERx Rare Appoints Bansi Nagji as CEO; Rob Snyder appointed Executive Chair
May 01, 2024
PANTHERx® Rare Pharmacy Wins Seventh Patient Choice Award
Apr 29, 2024
PANTHERx® Rare Partnering with X4 Pharmaceuticals Inc. for the Distribution of XOLREMDI(TM) (mavorixafor), the First FDA-Approved Therapy Indicated for Use in Patients with WHIM Syndrome
Apr 25, 2024
PANTHERx® Rare Continues Explosive Growth with Expansions of Pharmacy, HQ and Distribution Locations
Apr 01, 2024
PANTHERx®Rare Selected by Edenbridge Pharmaceuticals as Specialty Pharmacy for Yargesa® (miglustat 100 mg capsules)
Dec 03, 2020
PANTHERx Rare® Pharmacy Chosen as Partner by Alnylam Pharmaceuticals for OXLUMO(TM) (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary Oxalate Levels
Nov 20, 2020
Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, Named an EY Entrepreneur Of The Year® 2020 National Award Winner
Sep 14, 2020
PANTHERx® Rare Pharmacy Selected by Blueprint Medicines to Distribute GAVRETO(TM) (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
May 18, 2020
PANTHERx® Rare Pharmacy Selected by Deciphera Pharmaceuticals to Distribute QINLOCK(TM) (ripretinib), for Gastrointestinal Stromal Tumor (GIST) Patients
May 07, 2020
PANTHERx Rare Pharmacy Wins Patient Choice Award for a Record Third Time
May 04, 2020
White Paper "Rare Pharmacy Emerges from Specialty (Pharmacy)" Published
Latest News
Sep 2, 2025
BW LPG Limited Announces Sale of BW Lord
Sep 2, 2025
3D Printing Metals Company Benchmark Analysis Report 2025 | 3D Systems, Renishaw, and Stratasys Dominate with...
Sep 2, 2025
Måna Care AB Announces Strategic Sales Partnership with CareNova to Expand U.S. Reach
Sep 2, 2025
Chunghwa Telecom Receives Frost & Sullivan's 2025 Taiwan Company of the Year Recognition for...
Sep 2, 2025
FABTECH 2025 Preview: HSG Laser to Reveal Advanced Flat and Tube Laser Automation Solutions
Sep 2, 2025
Nouveau record des dépenses d'armement dans l'UE attendu en 2025
Sep 2, 2025
EU defence spending to hit record 380 bn euros in 2025
Sep 2, 2025
North Korea's Kim in China ahead of massive military parade
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events